472 related articles for article (PubMed ID: 16078761)
1. [Atrial natriuretic peptides: a new diagnostic tool for the internist].
Boari B; Manfredini R; Fellin R
Recenti Prog Med; 2005 Jun; 96(6):300-10. PubMed ID: 16078761
[TBL] [Abstract][Full Text] [Related]
2. Brain natriuretic peptide and acute coronary syndrome.
Mazzone M; Forte P; Portale G; Mancini F; Ursella S; La Sala M; Testa A; Covino M; Pignataro G; Gentiloni Silveri N
Minerva Med; 2005 Feb; 96(1):11-8. PubMed ID: 15827538
[TBL] [Abstract][Full Text] [Related]
3. [Brain natriuretic peptide].
Tsutamoto T; Horie M
Rinsho Byori; 2004 Aug; 52(8):655-68. PubMed ID: 15478621
[TBL] [Abstract][Full Text] [Related]
4. [The examination of clinical prognostic importance of atrial and brain natriuretic peptide in patients with acute myocardial infarction].
Mazurek W; Salomon P
Pol Merkur Lekarski; 2002 Jan; 12(67):15-9. PubMed ID: 11957795
[TBL] [Abstract][Full Text] [Related]
5. [Clinical applications of brain natriuretic peptide testing].
Scardovi AB; ; ; ; ;
Ital Heart J Suppl; 2004 May; 5(5):343-56. PubMed ID: 15182061
[TBL] [Abstract][Full Text] [Related]
6. Plasma natriuretic peptides up to 2 years after acute myocardial infarction and relation to prognosis: an OPTIMAAL substudy.
Squire IB; Ørn S; Ng LL; Manhenke C; Shipley L; Aarsland T; Dickstein K
J Card Fail; 2005 Sep; 11(7):492-7. PubMed ID: 16198243
[TBL] [Abstract][Full Text] [Related]
7. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
[TBL] [Abstract][Full Text] [Related]
8. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.
Ang DS; Kong CF; Kao MP; Struthers AD
Am Heart J; 2009 Jul; 158(1):133-40. PubMed ID: 19540403
[TBL] [Abstract][Full Text] [Related]
9. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction.
Richards AM; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton C; Turner J; Crozier IG; Yandle TG
Circulation; 2003 Jun; 107(22):2786-92. PubMed ID: 12771003
[TBL] [Abstract][Full Text] [Related]
10. B-type natriuretic peptide is an independent predictor for cardiovascular death in patients with no clinical signs of ventricular dysfunction after acute myocardial infarction.
Zhang Y; Wang L
Med Hypotheses; 2006; 67(5):1076-8. PubMed ID: 16697117
[TBL] [Abstract][Full Text] [Related]
11. B-type natriuretic peptide infusions in acute myocardial infarction.
Hillock RJ; Frampton CM; Yandle TG; Troughton RW; Lainchbury JG; Richards AM
Heart; 2008 May; 94(5):617-22. PubMed ID: 17639095
[TBL] [Abstract][Full Text] [Related]
12. [The role of natriuretic peptides in heart failure].
Ancona R; Limongelli G; Pacileo G; Miele T; Rea A; Roselli T; Masarone D; Messina S; Palmieri R; Golia E; Iacomino M; Gala S; Calabrò P; Di Salvo G; Calabrò R
Minerva Med; 2007 Oct; 98(5):591-602. PubMed ID: 18043566
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology, prognostic significance and clinical utility of B-type natriuretic peptide in acute coronary syndromes.
Wiviott SD; de Lemos JA; Morrow DA
Clin Chim Acta; 2004 Aug; 346(2):119-28. PubMed ID: 15256312
[TBL] [Abstract][Full Text] [Related]
14. Natriuretic peptides in assessment of left-ventricular dysfunction.
Mair J; Friedl W; Thomas S; Puschendorf B
Scand J Clin Lab Invest Suppl; 1999; 230():132-42. PubMed ID: 10389212
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.
de Lemos JA; Morrow DA; Bentley JH; Omland T; Sabatine MS; McCabe CH; Hall C; Cannon CP; Braunwald E
N Engl J Med; 2001 Oct; 345(14):1014-21. PubMed ID: 11586953
[TBL] [Abstract][Full Text] [Related]
16. [Atrial natriuretic peptides: diagnostic and therapeutic potential].
Brockhoff C; Warnholtz A; Münzel T
Ther Umsch; 2000 May; 57(5):305-12. PubMed ID: 10859990
[TBL] [Abstract][Full Text] [Related]
17. Comparison of plasma B-type natriuretic peptide levels in single ventricle patients with systemic ventricle heart failure versus isolated cavopulmonary failure.
Law YM; Ettedgui J; Beerman L; Maisel A; Tofovic S
Am J Cardiol; 2006 Aug; 98(4):520-4. PubMed ID: 16893709
[TBL] [Abstract][Full Text] [Related]
18. Combining natriuretic peptides and necrosis markers in determining prognosis in heart failure.
Fonarow GC; Horwich TB
Rev Cardiovasc Med; 2003; 4 Suppl 4():S20-8. PubMed ID: 14564225
[TBL] [Abstract][Full Text] [Related]
19. Health gains by using natriuretic peptides in diagnosis, prognosis and treatment.
Richards M; Troughton R; Lainchbury J; Doughty R; Wright S
Scand J Clin Lab Invest Suppl; 2005; 240():129-37. PubMed ID: 16112970
[TBL] [Abstract][Full Text] [Related]
20. Plasma natriuretic peptide levels and the risk of cardiovascular events and death.
Wang TJ; Larson MG; Levy D; Benjamin EJ; Leip EP; Omland T; Wolf PA; Vasan RS
N Engl J Med; 2004 Feb; 350(7):655-63. PubMed ID: 14960742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
